InstalabEhrlichia Chaffeensis Antibodies
Should you take a Ehrlichia Chaffeensis Antibodies test?
This test is most useful if any of these apply to you.
2 biomarkers included
- Ehrlichia Chaffeensis Antibody (IgG)Measures the long-lasting antibodies (IgG) your body builds against the bacterium. A single positive signals exposure, while a fourfold rise between two draws is the standard confirmation of a current infection.Why it mattersA fourfold rise in IgG between an early and a follow-up draw is the strongest serologic evidence of active human monocytic ehrlichiosis.
- Ehrlichia Chaffeensis Antibody (IgM)Measures the early-response antibodies (IgM) that tend to appear first and fade sooner. Paired with the long-lasting IgG antibody, it helps flag a very recent infection rather than old exposure.Why it mattersIgM positivity can point to recent infection but is prone to false positives, so it is never used alone to confirm the diagnosis.
About Ehrlichia Chaffeensis Antibodies
A tick bite in the wrong part of the country can leave you with more than an itchy welt. Ehrlichia chaffeensis, a bacterium carried by the lone star tick, infects a type of white blood cell and can cause fever, headache, and a drop in blood counts that sends a large share of recognized cases to the hospital. This panel looks for the fingerprint your immune system leaves behind: antibodies made specifically against that bacterium.
Reading these two antibody types together, and ideally across two blood draws, tells a story a single number cannot. It can separate a fresh infection from old exposure, and it fills in the picture when a tick-borne illness is on the table but the cause is still unclear.
What This Panel Reveals
When Ehrlichia chaffeensis enters your bloodstream, your immune system responds in a predictable sequence. Early-response antibodies (called IgM) tend to rise first and fade within weeks. Longer-lasting antibodies (called IgG) climb more slowly and can stay detectable for months after you recover. Measuring both captures where you sit on that timeline.
Neither antibody proves infection on its own. IgM can turn positive for reasons that have nothing to do with this bacterium, and a single IgG result cannot separate a current illness from one you cleared last summer. Read as a pair, and across time, they become far more informative than either alone.
How to Read Your Results Together
| Pattern | What It Suggests |
|---|---|
| IgG rises fourfold between two draws taken 2 to 4 weeks apart | The strongest serologic confirmation of a current, active infection |
| Single IgG positive at a low titer (such as 1:64), no follow-up draw | Points to past exposure; a low single titer is hard to interpret and cannot separate current from past infection on its own |
| IgM positive, IgG negative or low early in illness | Possible very recent infection; needs a follow-up draw to confirm |
| Both negative in the first week of symptoms | Does not rule out infection; antibodies are often absent early |
Timing is everything here. In culture-confirmed cases, the long-term antibody test caught only 33 percent of patients and the early antibody test 44 percent at the first visit, using a lab technique called indirect immunofluorescence assay (IFA). In one Missouri series, 31 percent of first-draw samples fell below the positive threshold entirely. A second draw weeks later is far more revealing: in a North Carolina health system, follow-up samples were positive 61.7 percent of the time versus 27.0 percent for the first draw.
One caution applies to both tests. These antibodies can cross-react, so a positive result can reflect a closely related organism, such as another Ehrlichia species or the bacterium behind anaplasmosis, rather than E. chaffeensis itself. Roughly 1 in 10 people in areas where the lone star tick thrives already carry antibodies from a past exposure, though local rates vary widely, which is another reason a lone positive result rarely settles the question.
What to Do with Your Results
If you have a fever after a possible tick bite, do not wait on antibody results to act. Antibodies lag the illness, so a negative early test is common even when you are infected. A DNA-based blood test (PCR) can detect the bacterium directly in the first week, when antibodies are still catching up. It was positive in every patient in one small study of culture-confirmed cases, though its real-world sensitivity across all patients is lower, roughly 50 to 90 percent depending on timing. A blood count showing low white cells or platelets, or elevated liver enzymes, strengthens the case.
Prompt doxycycline is the standard treatment, and early treatment is consistently linked to better outcomes, while delay is linked to severe complications that fall hardest on people with weakened immune systems. If your first draw is negative or borderline, a convalescent sample 2 to 4 weeks later is what actually confirms or clears the diagnosis. Bring any positive result to a clinician who can weigh your symptoms, timing, and exposure history.